Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Miura

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Oncology Letters|March 15, 2019
Dual inhibition of MEK and p38 impairs tumor growth in <i>KRAS</i>-mutated non-small cell lung cancerNoriaki Sunaga, Yosuke Miura, Yusuke Tsukagoshi, et al.
Oncology Letters|August 10, 2017
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitorsYosuke Miura, Kyoichi Kaira, Reiko Sakurai, et al.
Chemotherapy|April 6, 2017
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line ChemotherapyMie Kotake, Yosuke Miura, Hisao Imai, et al.
International Journal of Clinical Oncology|May 28, 2017
High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinomaYosuke Miura, Kyoichi Kaira, Reiko Sakurai, et al.
Frontiers in Oncology|August 21, 2025
A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancerYosuke Miura, Nobuteru Kubo, Noriaki Sunaga, et al.
Case Reports in Oncology|June 12, 2019
Successful Treatment of Gastrosplenic Fistula Arising from Diffuse Large B-Cell Lymphoma with Chemotherapy: Two Case ReportsMakoto Saito, Kencho Miyashita, Yosuke Miura, et al.
International Journal of Clinical Oncology|October 11, 2014
Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancerYuichi Takiguchi, Shunichiro Iwasawa, Koichi Minato, et al.
Cancer Chemotherapy and Pharmacology|November 11, 2017
A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancerReiko Sakurai, Yoshio Tomizawa, Akihiro Yoshii, et al.
International Journal of General Medicine|September 27, 2018
Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case reportMakoto Saito, Kencho Miyashita, Yosuke Miura, et al.
Canadian Respiratory Journal|June 6, 2022
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of SarcoidosisNoriaki Sunaga, Yasuhiko Koga, Yoshimasa Hachisu, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Oncology Letters|March 15, 2019
Dual inhibition of MEK and p38 impairs tumor growth in <i>KRAS</i>-mutated non-small cell lung cancerNoriaki Sunaga, Yosuke Miura, Yusuke Tsukagoshi, et al.
Oncology Letters|August 10, 2017
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitorsYosuke Miura, Kyoichi Kaira, Reiko Sakurai, et al.
Chemotherapy|April 6, 2017
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line ChemotherapyMie Kotake, Yosuke Miura, Hisao Imai, et al.
International Journal of Clinical Oncology|May 28, 2017
High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinomaYosuke Miura, Kyoichi Kaira, Reiko Sakurai, et al.
Frontiers in Oncology|August 21, 2025
A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancerYosuke Miura, Nobuteru Kubo, Noriaki Sunaga, et al.
Case Reports in Oncology|June 12, 2019
Successful Treatment of Gastrosplenic Fistula Arising from Diffuse Large B-Cell Lymphoma with Chemotherapy: Two Case ReportsMakoto Saito, Kencho Miyashita, Yosuke Miura, et al.
International Journal of Clinical Oncology|October 11, 2014
Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancerYuichi Takiguchi, Shunichiro Iwasawa, Koichi Minato, et al.
Cancer Chemotherapy and Pharmacology|November 11, 2017
A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancerReiko Sakurai, Yoshio Tomizawa, Akihiro Yoshii, et al.
International Journal of General Medicine|September 27, 2018
Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case reportMakoto Saito, Kencho Miyashita, Yosuke Miura, et al.
Canadian Respiratory Journal|June 6, 2022
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of SarcoidosisNoriaki Sunaga, Yasuhiko Koga, Yoshimasa Hachisu, et al.
Pageof 5